Loading…
Nektar Therapeutics is projected to rise to $96.56 by 2027, a +32% move from its current price of $72.92. NKTR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $70.50 | $72.99 | $75.57 | +0.10% |
| Jul 13 | $69.56 | $73.06 | $76.74 | +0.20% |
| Jul 14 | $68.87 | $73.14 | $77.67 | +0.30% |
| Jul 15 | $68.30 | $73.21 | $78.47 | +0.40% |
| Jul 16 | $67.81 | $73.28 | $79.20 | +0.50% |
| Jul 17 | $67.37 | $73.35 | $79.87 | +0.59% |
| Jul 18 | $66.98 | $73.43 | $80.49 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $66.98 | $73.43 | $80.49 | +0.69% |
| Week 2 | $64.93 | $73.94 | $84.19 | +1.39% |
| Week 3 | $63.49 | $74.45 | $87.29 | +2.10% |
| Week 4 | $62.38 | $74.96 | $90.09 | +2.80% |
| Week 5 | $61.47 | $75.48 | $92.70 | +3.52% |
| Week 6 | $60.69 | $76.01 | $95.19 | +4.24% |
| Week 7 | $60.02 | $76.54 | $97.60 | +4.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nektar Therapeutics is a biopharmaceutical company that focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large B-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F.
Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorporated in 1990 and is headquartered in San Francisco, California.
NKTR is current price $71.04 with a market cap of $2.4B and a rank of 1867. The stock sits in the Healthcare sector and is characterized by a bullish near-term technical tone. The current price and market position are complemented by a multi-year forecast that points to meaningful upside from 2027 through 2050.
A major floor 33.5% below — a decisive break under it would weaken the trend.
The nearest floor, 22.9% below — buyers have tended to step in here.
Price is pressing into resistance (2.7% away) — a breakout level to watch.
A major ceiling 37.6% above — clearing it would confirm fresh momentum.
Key NKTR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NKTR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $72.65 | Buy | $71.39 | Buy |
| MA 10 | $69.75 | Buy | $69.88 | Buy |
| MA 20 | $65.93 | Buy | $67.83 | Buy |
| MA 50 | $68.85 | Buy | $68.23 | Buy |
| MA 100 | $72.50 | Buy | $67.09 | Buy |
| MA 200 | $62.20 | Buy | $59.80 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.70 | Neutral |
| Stoch RSI (14) | 54.09 | Neutral |
| CCI (20) | 68.15 | Neutral |
| Williams %R (14) | -35.28 | Info |
| MACD (12,26,9) | 1.21 | Buy |
| ROC (12) | 5.50 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 64.72 | Neutral |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | 8.45 | Buy |
| Ultimate (7,14,28) | 54.68 | Neutral |
| Momentum (10) | 8.33 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 73.62 | Sell |
| ADX (14) | 21.27 | Buy |
| ATR (14) | 2.30 | Info |
The sentiment is BULLISH with an RSI of 60. The 50-day simple moving average stands at $70.51 and the 200-day average at $61.75, outlining a constructive trend. Support is at $56.23 and resistance at $71.04, framing a near-term range that aligns with the current price.
The 30-day range spans from $55.45 to $91.01, indicating volatility and potential for movement within that band. Annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $35.12 | $72.92 | $106.62 | 0% | Neutral | |
| $74.93 | $96.56 | $132.77 | +32% | Bullish | |
| $81.49 | $108.92 | $156.69 | +49% | Bullish | |
| $82.44 | $113.62 | $169.29 | +56% | Bullish | |
| $87.02 | $123.22 | $189.08 | +69% | Bullish | |
| $88.89 | $129.04 | $203.13 | +77% | Bullish | |
| $104.16 | $154.79 | $249.28 | +112% | Bullish | |
| $136.38 | $207.18 | $340.59 | +184% | Bullish | |
| $136.48 | $211.74 | $354.72 | +190% | Bullish | |
| $137.29 | $217.36 | $370.56 | +198% | Bullish | |
| $200.26 | $348.05 | $638.13 | +377% | Bullish | |
| $309.00 | $634.62 | $1,291.87 | +770% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $35.12 | $72.92 | $87.48 | +0.00% |
| August 2026 | $62.97 | $74.89 | $91.86 | +2.70% |
| September 2026 | $66.50 | $79.79 | $99.24 | +6.55% |
| October 2026 | $67.33 | $81.42 | $102.45 | +2.04% |
| November 2026 | $66.15 | $80.52 | $102.31 | -1.11% |
| December 2026 | $67.91 | $83.16 | $106.62 | +3.29% |
Click any year to see its month-by-month NKTR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NKTR price prediction for 2026 points to an average of $72.92 (low $35.12, high $106.62) — a potential gain of 0% on today's $72.92. Price action looks broadly range-bound.
In 2027, NKTR is projected to trade between $74.93 and $132.77, averaging $96.56 — a potential gain of +32% from today's $72.92. That is up +32% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Nektar Therapeutics's 2028 outlook centres on $108.92, within a $81.49 to $156.69 range. That is up +13% on the projected 2027 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2029, NKTR could reach as high as $169.29, with a base case around $113.62 and support toward $82.44 — roughly +56% from $72.92. Buyers look set to stay in control over this stretch.
Expect NKTR to range from $87.02 to $189.08 through 2030. The $123.22 average target implies a +69% move from current prices. That is up +8% on the projected 2029 average. Momentum favours further upside here.
The NKTR price prediction for 2031 points to an average of $129.04 (low $88.89, high $203.13) — a potential gain of +77% on today's $72.92. Buyers look set to stay in control over this stretch.
In 2032, NKTR is projected to trade between $104.16 and $249.28, averaging $154.79 — a potential gain of +112% from today's $72.92. That is up +20% on the projected 2031 average. Momentum favours further upside here.
Nektar Therapeutics's 2033 outlook centres on $207.18, within a $136.38 to $340.59 range. That is up +34% on the projected 2032 average. That marks a +184% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NKTR could reach as high as $354.72, with a base case around $211.74 and support toward $136.48 — roughly +190% from $72.92. Momentum favours further upside here.
Expect NKTR to range from $137.29 to $370.56 through 2035. The $217.36 average target implies a +198% move from current prices. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The NKTR price prediction for 2040 points to an average of $348.05 (low $200.26, high $638.13) — a potential gain of +377% on today's $72.92. Momentum favours further upside here.
In 2050, NKTR is projected to trade between $309.00 and $1,291.87, averaging $634.62 — a potential gain of +770% from today's $72.92. That is up +82% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NKTR today (≈ 13.713659 NKTR) could be worth
$8,703
+$7,703 (+770%) by 2050 · US Dollar
Based on the average projected NKTR price of $634.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NKTRwould be worth at today's price.
$1,000 invested in NKTR on Jul 10, 2025 (≈ 39.840637 NKTR) would be worth
$2,905.18
+$1,905.18 (+190.5%) today · 2.91× · US Dollar
Based on a NKTR entry price of $25.1 vs. today's $72.92.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $71.04 | $1,026.46 | +2.6% |
| 1 month ago | $56.78 | $1,284.26 | +28.4% |
| 3 months ago | $77.5 | $940.9 | -5.9% |
| 6 months ago | $38.77 | $1,880.84 | +88.1% |
| 1 year ago | $25.1 | $2,905.18 | +190.5% |
| All time (5.0y) ago | $258.45 | $282.14 | -71.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NKTR forecast.
Our base-case forecast reaches $150.00 around 2032.
Implied market cap at $150.00: $5.07B
The multi-year forecast shows a path of upside from 2026 onward. The 2026 forecast has an avg of $71.04 with a min of $35.12 and a max of $106.68, with a neutral sentiment and ROI of 0. From 2027 to 2035 the averages rise meaningfully: 2027 $93.47, 2028 $105.11, 2029 $109.40, 2030 $114.36, 2031 $119.56, 2032 $145.47, 2033 $192.34, 2034 $195.88, and 2035 $202.08, all with bullish sentiment and ROI values ranging from 31.6 to 184.5.
By 2040 the avg price is forecast at $316.23 with ROI 345.1 and a bullish stance, and by 2050 the avg price is $570.12 with ROI 702.5, also bullish. These figures imply substantial potential upside over the long horizon, though they are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an avg of $114.36 with a ROI of 61 and a bullish sentiment.
The forecast turns bullish from 2027 onward, with rising averages and positive ROI across multiple years, suggesting upside potential though these figures are estimates.
Yes. The 2035 forecast shows an avg of $202.08, indicating the asset could cross around the $200 level by 2035 on average estimates.
The 2026 forecast shows an avg of $71.04 with a ROI of 0 and a neutral sentiment.
The 2050 forecast shows an avg of $570.12 with a ROI of 702.5 and a bullish sentiment.
Nektar Therapeutics Community Discussion
0Share your Nektar Therapeutics price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.